Imaging the Alzheimer Brain

Overview

Journal J Alzheimers Dis

Publisher Sage Publications

Specialties Geriatrics
Neurology

Date 2011 Oct 6

PMID 21971448

Citations 12

Authors

J Wesson Ashford

Ahmad Salehi

Ansgar Furst

Peter Bayley

Giovanni B Frisoni

Clifford R Jack Jr

Osama Sabri

Maheen M Adamson

Kerry L Coburn

John Olichney

Norbert Schuff

Daniel Spielman

Steven D Edland

Sandra Black

Allyson Rosen

David Kennedy

Michael Weiner

George Perry

Affiliations

Soon will be listed here.

Citing Articles

A Review on Phyto-Therapeutic Approaches in Alzheimer's Disease.

Sahiner M, Yilmaz A, Gungor B, Sahiner N J Funct Biomater. 2023; 14(1).

PMID: 36662097 PMC: 9861153. DOI: 10.3390/jfb14010050.

Role of Chemokines in the Development and Progression of Alzheimer's Disease.

Wojcieszak J, Kuczynska K, Zawilska J J Mol Neurosci. 2022; 72(9):1929-1951.

PMID: 35821178 PMC: 9392685. DOI: 10.1007/s12031-022-02047-1.

A Brief Introduction to Magnetoencephalography (MEG) and Its Clinical Applications.

Fred A, Kumar S, Kumar Haridhas A, Ghosh S, Purushothaman Bhuvana H, Khang Jeremy Sim W Brain Sci. 2022; 12(6).

PMID: 35741673 PMC: 9221302. DOI: 10.3390/brainsci12060788.

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease.

Mila-Aloma M, Suarez-Calvet M, Molinuevo J Ther Adv Neurol Disord. 2020; 12:1756286419888819.

PMID: 31897088 PMC: 6920596. DOI: 10.1177/1756286419888819.

Gu T, Fu C, Shen Z, Guo H, Zou M, Chen M Front Aging Neurosci. 2019; 11:85.

PMID: 31105550 PMC: 6492052. DOI: 10.3389/fnagi.2019.00085.

References

Coburn K, Lauterbach E, Boutros N, Black K, Arciniegas D, Coffey C . The value of quantitative electroencephalography in clinical psychiatry: a report by the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 2006; 18(4):460-500. DOI: 10.1176/jnp.2006.18.4.460. View

Geddes J, Tekirian T, Soultanian N, Ashford J, Davis D, Markesbery W . Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging. 1997; 18(4 Suppl):S99-105. DOI: 10.1016/s0197-4580(97)00063-8. View

Fleisher A, Sherzai A, Taylor C, Langbaum J, Chen K, Buxton R . Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage. 2009; 47(4):1678-90. PMC: 2722694. DOI: 10.1016/j.neuroimage.2009.06.021. View

Petrella J, Krishnan S, Slavin M, Tran T, Murty L, Doraiswamy P . Mild cognitive impairment: evaluation with 4-T functional MR imaging. Radiology. 2006; 240(1):177-86. DOI: 10.1148/radiol.2401050739. View

Geroldi C, Pihlajamaki M, Laakso M, DeCarli C, Beltramello A, Bianchetti A . APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology. 1999; 53(8):1825-32. DOI: 10.1212/wnl.53.8.1825. View

Ashford J . ApoE4: is it the absence of good or the presence of bad?. J Alzheimers Dis. 2002; 4(3):141-3. DOI: 10.3233/jad-2002-4303. View

Moore N, Vogel R, Tucker K, Khairy N, Coburn K . P2 flash visual evoked response delay may be a marker of cognitive dysfunction in healthy elderly volunteers. Int Psychogeriatr. 1996; 8(4):549-59. DOI: 10.1017/s1041610296002876. View

Raber J, Huang Y, Ashford J . ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging. 2004; 25(5):641-50. DOI: 10.1016/j.neurobiolaging.2003.12.023. View

Teipel S, Meindl T, Wagner M, Kohl T, Burger K, Reiser M . White matter microstructure in relation to education in aging and Alzheimer's disease. J Alzheimers Dis. 2009; 17(3):571-83. DOI: 10.3233/JAD-2009-1077. View

10.

Rombouts S, Goekoop R, Stam C, Barkhof F, Scheltens P . Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. Neuroimage. 2005; 26(4):1078-85. DOI: 10.1016/j.neuroimage.2005.03.022. View

11.

Roberson E, Halabisky B, Yoo J, Yao J, Chin J, Yan F . Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci. 2011; 31(2):700-11. PMC: 3325794. DOI: 10.1523/JNEUROSCI.4152-10.2011. View

12.

McKee A, Cantu R, Nowinski C, Hedley-Whyte E, Gavett B, Budson A . Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol. 2009; 68(7):709-35. PMC: 2945234. DOI: 10.1097/NEN.0b013e3181a9d503. View

13.

Fennema-Notestine C, Panizzon M, Thompson W, Chen C, Eyler L, Fischl B . Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age. J Alzheimers Dis. 2011; 26 Suppl 3:49-60. PMC: 3302177. DOI: 10.3233/JAD-2011-0002. View

14.

Fellgiebel A, Yakushev I . Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease. J Alzheimers Dis. 2011; 26 Suppl 3:257-62. DOI: 10.3233/JAD-2011-0001. View

15.

Schacter D, Wagner A . Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus. 1999; 9(1):7-24. DOI: 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K. View

16.

Struble R, Cork L, Whitehouse P, Price D . Cholinergic innervation in neuritic plaques. Science. 1982; 216(4544):413-5. DOI: 10.1126/science.6803359. View

17.

Fleisher A, Grundman M, Jack Jr C, Petersen R, Taylor C, Kim H . Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol. 2005; 62(6):953-7. DOI: 10.1001/archneur.62.6.953. View

18.

Austin B, Nair V, Meier T, Xu G, Rowley H, Carlsson C . Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis. 2011; 26 Suppl 3:123-33. PMC: 3303148. DOI: 10.3233/JAD-2011-0010. View

19.

Furst A, Lal R . Amyloid-β and glucose metabolism in Alzheimer's disease. J Alzheimers Dis. 2011; 26 Suppl 3:105-16. DOI: 10.3233/JAD-2011-0066. View

20.

Babiloni C, Pievani M, Vecchio F, Geroldi C, Eusebi F, Fracassi C . White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment. Hum Brain Mapp. 2008; 30(5):1431-43. PMC: 6871072. DOI: 10.1002/hbm.20612. View